Immunodiagnosis of Fasciola hepatica infection (Fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase

American Journal of Tropical Medicine and Hygiene

Volumn 58, Issue 4, 1998, Pages 417-423

  O'Neill, Sandra M ^a   Parkinson, Michael ^a   Strauss, Wilma ^a,b   Angles, Rene ^b   Dalton, John P ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b Caja Nacional de Salud   (Bolivia)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BOLIVIA; CHILD; CLUSTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FASCIOLA HEPATICA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PARASITE ISOLATION; PREVALENCE; SERODIAGNOSIS;

EID: 0031953806     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.58.417     Document Type: Article

References (19)

1. Massoud J, 1990. Fascioliasis outbreak in man and drug test (triclabendazole) in Caspian littoral, northern part of Iran, 1989. Bull Soc Fran Parasitol 8: 438.
2. Knobloch J, 1985. Human fascioliasis in Cajamarca/Peru: humoral antibody response and antigenaemia. Trop Med Parasitol 36: 91-93.
3. Espino AM, Finlay CM, 1994. Sandwich enzyme-linked immunosorbent assay for detection of excretory-secretory antigens in humans with fascioliasis. J Clin Microbiol 32: 190-193.
4. Hillyer GV, De Galanes MS, Rodriguez-Perez J, De Lagrava MS, Bjorland J, De Lagrava, MS, Ramirez Guzman S, Bryan RT, 1992. Use of the Falcon™ assay screening test-enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immunoelectrotransfer blot (ETIB) to determine the prevalence of human fascioliasis in the Bolivian Altiplano. Am J Trop Med Hyg 46: 603-609.
5. Bjorland J, Byran RT, Strauss W, Hillyer GV, McAuley JB, 1995. An outbreak of acute fascioliasis among Aymara Indians in the Bolivian Altiplano. Clin Infect Dis 21: 1228-1233.
6. Esteban JG, Flores A, Aguirre C, Strauss W, Angles R, MasComa S, 1997. Presence of very high prevalence and intensity of infection with Fasciola hepatica among Aymara children from the northern Bolivian Altiplano. Acta Trop 66: 1-14.
7. Chen MG, Mott KE, 1990. Progress in morbidity due to Fasciola hepatica infection. Trop Dis Bull 87: 1-37.
8. Arjona R, Riancho J, Aguado J, Salesa R, Gonzalez-Macias J, 1995. Fascioliasis in developed countries: a review of classic and aberrant forms of the disease. Medicine 74: 13-23.
9. Silva Sampaio ML, Correia da Costa JM, Viana da Costa AM, Pires MA, Lopes SA, Castro AM, Monjour L, 1996. Antigenic components of excretory-secretory products of adult Fasciola hepatica recognized in human infections. Am J Trop Med Hyg 54: 146-148.
10. Smith A, Dowd A, McGonigle SM, Keegan P, Brennan G, Trudgett A, Dalton JP. 1993. Purification of a cathepsin L-like proteinase secreted by adult Fasciola hepatica. Mol Biochem Parasitol 62: 1-8.
11. Katz N, Chaves A, Pellegrino J, 1972. A simple device for quantitative stool thick smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14: 397-402.
12. Vaz AJ, Ferrerira AW, 1988. Immunodiagnosis of neurocysticercosis: immunoenzymatic assay with antigens chemically bound to supports to detect antibodies in serum and cerebrospinal fluid. Rev Inst Med Trop Sao Paulo 30: 1-10.
13. Dalton JP, Heffernan M, 1989. Thiol protease released in vitro by Fasciola hepatica. Mol Biochem Parasitol 35: 161-166.
14. Dowd AJ, Smith AM, McGonigle SM, Dalton JP, 1994. Purification and characterisation of a second cathepsin L proteinase secreted by the parasite trematode Fasciola hepatica. Eur J Biochem 223: 91-98.
15. Smith A, Dowd AJ, Heffernan M, Robertson C, Dalton JP, 1993. Fasciola hepatica: a secreted cathepsin L-like proteinase cleaves host immunoglobulin. Int J Parasitol 23: 977-983.
16. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B, 1995. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci 50: 378-382.
17. Kimura K, Isogai E, Isogai H, Nishikawa T, Masuzawa T, Yoshikawa K, Kotake S, Ohno S, Fujii N, 1995. Prevalence of antibodies against Borrelia species in patients with unclassified uveitis in regions in which Lyme disease is endemic and non-endemic. Clin Diagn Lab Immun 2: 53-56.
18. Prokpowicz Bobrowsta E, Bobrowsti M, Grzeszcuk A, 1995. Prevalence of antibodies against tick-borne encephalitis among residents of north-eastern Poland. Scand J Infect Dis 27: 15-16.
19. Shiddo SA, Aden Mohamed A, Akuffo HO, Mohamud KA, Herzi AA, Herzi Mohamed H, Huldt G, Nilsson LA, Ouchterlony O, Thorstensson R, 1995. Visceral leishmaniasis in Somalia: prevalence of markers of infection and disease manifestations in a village in an endemic area. Trans R Soc Trop Med Hyg 89: 361-365.